TARRYTOWN, N.Y. and CAMBRIDGE, Mass., June 1, 2020 /PRNewswire/ — Regeneron and Intellia to co-develop potential hemophilia A and B treatments using their jointly-owned targeted transgene insertion capabilities...
Emerging technologies
Ginkgo Bioworks to Build Infrastructure for Rapid Epidemic Response with $70MM Investment
Strategic investment from Illumina and others enables large-scale COVID-19 testing using next generation sequencing BOSTON, May 28, 2020 /PRNewswire/ — Today, Ginkgo Bioworks is announcing a $70MM investment...
